most undervalued pharmaceutical Anyone watching this? i got in 70c (could have waited in retrospect - as always). Genepharm recently bought Douglas pharmaceutical for 70mil - a company with annual revenue of 55mil (no other figures given). LIP has half yrly revenue of 37mil. I KNOW - revenue means nothing coz profit is all that matters. i still think its undervalued with a market cap of 65mil at the moment. Any thoughts out there?
- Forums
- ASX - By Stock
- LIP
- crashed almost 50% on ann
LIP
lipa pharmaceuticals limited
crashed almost 50% on ann, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online